CH
HALO icon

Cromwell Holdings’s Halozyme HALO Stock Holding History

Cromwell Holdings’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74K Buy
35
+13
+59% +$886 ﹤0.01% 783
2026
Q1 		$1.42K Hold
22
– – ﹤0.01% 774
2025
Q4 		$1.48K Hold
22
– – ﹤0.01% 742
2025
Q3 		$1.61K Buy
22
+11
+100% +$731 ﹤0.01% 740
2025
Q2 		$572 Buy
+11
New +$626 ﹤0.01% 949

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Cromwell Holdings's HALO Position: Q2 2026 in Review

Cromwell Holdings increased its Halozyme (HALO) stake by 59% in Q2 2026, buying an estimated $886 and bringing the position to 35 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Cromwell Holdings first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Cromwell Holdings held 35 shares of Halozyme worth $2.74K as of Q2 2026.
  • Cromwell Holdings bought 13 Halozyme shares in Q2 2026, an estimated $886.
  • Halozyme made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #783 holding.
  • Cromwell Holdings first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.